Join
Live feed
·
INSIDERFilingvia Quantisnow
Cerevel Therapeutics Holdings Inc. logo

Bodenrader Mark converted options into 19,284 shares and sold $326,788 worth of shares (7,889 units at $41.42), increasing direct ownership by 180% to 17,724 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CERE (Cerevel Therapeutics Holdings Inc.) and more on Quantisnow.